FTY720 promotes local microvascular network formation and regeneration of cranial bone defects

Tissue Engineering - Part A

Volumn 16, Issue 6, 2010, Pages 1801-1809

  Aronin, Caren E Petrie ^a   Sefcik, Lauren S ^a   Tholpady, Sunil S ^b   Tholpady, Ashok ^c   Sadik, Karim W ^c   MacDonald, Timothy L ^b   Peirce, Shayn M ^a   Wamhoff, Brian R ^c   Lynch, Kevin R ^c   Ogle, Roy C ^a,b,c   Botchwey, Edward A ^a,c  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; BONE; DEFECT DENSITY;

BONE INGROWTH; CALVARIAL BONES; CRANIAL BONE; DURA MATER; IN-VITRO; MICROENVIRONMENTS; MICROVASCULAR NETWORK; MICROVESSEL DENSITY; MICROVESSELS; SELECTIVE ACTIVATION; SMOOTH MUSCLE CELLS; SPHINGOSINE 1 PHOSPHATES;

DEFECTS;

DRUG DERIVATIVE; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BONE DISEASE; BONE REGENERATION; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; MALE; MICRO-COMPUTED TOMOGRAPHY; MICROVASCULATURE; PATHOLOGY; RADIOGRAPHY; RAT; SKULL; SPRAGUE DAWLEY RAT;

ANIMALS; BONE DISEASES; BONE REGENERATION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROVESSELS; PROPYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOSPHINGOLIPID; SKULL; SPHINGOSINE; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 77953339728     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0539     Document Type: Article

References (26)

1. LeDouarin, N.M., and Dupin, E. Multipotentiality of the neural crest. Curr Opin Genet Dev 13, 529, 2003.
2. Sieber-Blum, M., Grim, M., Hu, Y.F., and Szeder, V. Plur-ipotent neural crest stem cells in the adult hair follicle. Dev Dyn 231, 258, 2004.
3. Opperman, L.A., Passarelli, R.W., Nolen, A.A., Gampper, T.J., Lin, K.Y.K., and Ogle, R.C. Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev Biol 32, 627, 1996.
4. Opperman, L.A., Chhabra, A., Cho, R.W., and Ogle, R.C. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-b3 activity and prevented by removal of TGF-b2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 19, 164, 1999.
5. Opperman, L.A., Passarelli, R.W., Morgan, E.P., Reintjes, M., and Ogle, R.C. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 10, 1978, 1995.
6. Reid, C.A., McCarthy, J.G., and Kolber, A.B. A study of regeneration in parietal bone defects in rabbits. Plast Reconstr Surg 67, 591, 1981.
7. Spector, J.A., Greenwald, J.A., Warren, S.M., Bouletreau, P.J., Detch, R.C., Fagenholz, P.J., Crisera, F.E., and Longaker, M.T. Dura mater biology: autocrine and paracrine effects of fibroblast growth factor 2. Plast Reconstr Surg 109, 645, 2002.
8. Gagan, J.R., Tholpady, S.S., and Ogle, R.C. Cellular dynamics and tissue interactions of the dura mater during head development. Birth Defects Res C Embryo Today 81, 297, 2007.
9. Petrie, C.E., Tholpady, S.S., Ogle, R.C., and Botchwey, E.A. Proliferative capacity and osteogenic potential of novel dura mater stem cells on poly-lactic-co-glycolic acid. J Biomed Mater Res A 85, 61, 2008.
10. Jain, R.K. Molecular regulation of vessel maturation. Nat Med 9, 685, 2003.
11. Henry, T.D., Annex, B.H., McKendall, G.R., Azrin, M.A., Lopez, J.J., Giordano, F.J., Shah, P.K., Willerson, J.T., Benza, R.L., Berman, D.S., Gibson, C.M., Bajamonde, A., Rundle, A.C., Fine, J., and McCluskey, E.R.; and VIVA Investigators. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107, 1359, 2003.
12. Barnard, G.C., McCool, J.D., Wood, D.W., and Gerngross, T.U. Integrated recombinant protein expression and purification platform base don ralsonia eutrpha. Appl Environ Microbiol 71, 5735, 2005.
13. Sefcik, L.S., Petrie Aronin, C.E., Wieghaus, K.A., and Botch-wey, E.A. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. Bio-materials 29, 2869, 2008.
14. Wamhoff, B.R., Lynch, K.R., Macdonald, T.L., and Owens, G.K. Sphingosine 1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 28, 1454, 2008.
15. Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.X., Hobson, J.P., Rosenfeldt, H.M., Nava, V.E., Chae, S.S., Lee, M.J., Liu, C.H., Hla, T., Spiegel, S., and Proia, R.L. Edg-1, the G protein-coupled receptor for sphingosine 1-phosphate, is essential for vascular maturation. J Clin Invest 106, 951, 2000.
16. Petrie Aronin, C.E., Sadik, K.W., Lay, A.L., Rion, D.B., Tholpady, S.S., Ogle, R.C., and Botchwey, E.A. Comparative effects of scaffold pore size, pore volume, and total void volume on cranial bone healing patterns using microsphere-based scaffolds. J Biomed Mater Res A 89, 632, 2009.
17. Bolick, D.T., Srinivasan, S., Kim, K.W., Hatley, M.E., Clemens, J.J., Whetzel, A., Ferger, N., Macdonald, T.L., Davis, M.D., Tsao, P.S., Lynch, K.R., and Hedrick, C.C. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler Thromb Vasc Biol 25, 976, 2005.
18. Collins-Osdoby, P. Role of vascular endothelial cells in bone biology. J Cell Biochem 55, 304, 1994.
19. Streeten, E.A., and Brandi, M. Biology of bone endothelial cells. Bone Miner 10, 85, 1990.
20. Trueta, J., and Little, K. The vascular contribution to osteo-genesis. II. Studies with the electron microscope. J Bone Joint Surg Br 42B, 367, 1960.
21. Caplan, A., Syftestad, G., and Osdoby, R. The development of embryonic bone and cartilage in tissue culture. Clin Or-thop Relat Res 174, 243, 1983.
22. Drushel, R.F., Pechak, D.G., and Caplan, A.I. The anatomy, ultrastructure and fluid dynamics of the developing vascu-lature of the embryonic chick wing bud. Cell Differ 16, 13, 1985.
23. 3 receptor. Arterioscler Thromb Vasc Biol 27, 275, 2007.
24. Ishii, M., Egen, J.G., Klauschen, F., Meier-Schellersheim, M., Saeki, Y., Vacher, J., Proia, R.L., and Germain, R.N. Sphin-gosine 1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458, 524, 2009.
25. Grey, A., Xu, X., Hill, B., Watson, M., Callon, K., Reid, I.R., and Cornish, J. Osteoblastic cells express phospho-lipids receptors and phosphatases and proliferate in response to sphingosine 1-phosphate. Calcif Tissue Int 74, 542, 2004.
26. Peng, X., Hassoun, P.M., Sammani, S., McVerry, B.J., Burne, M.J., Rabb, H., Pearse, D., Tuder, R.M., and Garcia, J.G. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 164, 1245, 2004.